Entity Common Stock, Shares Outstanding of Horizon Therapeutics Public Ltd Co from 31 Aug 2011 to 02 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Horizon Therapeutics Public Ltd Co quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2011 to 02 Aug 2023.
  • Horizon Therapeutics Public Ltd Co Entity Common Stock, Shares Outstanding for the quarter ending 02 Aug 2023 was 228,994,568, a 0.6% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Horizon Therapeutics Public Ltd Co Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 228,994,568 -1,389,805 -0.6% 02 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 228,621,802 -1,262,275 -0.55% 27 Apr 2023 10-Q 03 May 2023 2023 Q1
Q3 2022 226,621,465 -199,549 -0.09% 27 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 230,384,373 +4,490,998 +2% 28 Jul 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 229,884,077 +5,115,526 +2.3% 28 Apr 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 226,821,014 +6,110,928 +2.8% 28 Oct 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 225,893,375 +19,433,004 +9.4% 29 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 224,768,551 +33,990,164 +18% 29 Apr 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 220,710,086 +33,407,857 +18% 28 Oct 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 206,460,371 +20,012,551 +11% 31 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 190,778,387 +5,894,506 +3.2% 01 May 2020 10-Q 06 May 2020 2020 Q1
Q3 2019 187,302,229 +19,676,314 +12% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 186,447,820 +19,818,082 +12% 01 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 184,883,881 +19,842,818 +12% 01 May 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 167,625,915 +3,740,112 +2.3% 26 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 166,629,738 +3,275,470 +2% 27 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 165,041,063 +2,331,104 +1.4% 27 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 163,885,803 +2,628,384 +1.6% 27 Oct 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 163,354,268 +2,449,394 +1.5% 28 Jul 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 162,709,959 +2,353,254 +1.5% 28 Apr 2017 10-Q 08 May 2017 2017 Q1
Q3 2016 161,257,419 +1,964,249 +1.2% 02 Nov 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 160,904,874 +1,703,749 +1.1% 29 Jul 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 160,356,705 +5,857,733 +3.8% 29 Apr 2016 10-Q 09 May 2016 2016 Q1
Q3 2015 159,293,170 +40,440,380 +34% 02 Nov 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 159,201,125 +84,431,478 +113% 03 Aug 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 154,498,972 +86,765,555 +128% 01 May 2015 10-Q 08 May 2015 2015 Q1
Q3 2014 118,852,790 +52,995,104 +80% 03 Nov 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 74,769,647 +10,276,899 +16% 05 Aug 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 67,733,417 +5,786,170 +9.3% 11 Mar 2014 10-K 13 Mar 2014 2013 FY
Q3 2013 65,857,686 +4,273,321 +6.9% 05 Nov 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 64,492,748 +30,705,568 +91% 06 Aug 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 61,947,247 +28,243,877 +84% 13 Mar 2013 10-K 18 Mar 2013 2012 FY
Q3 2012 61,584,365 +42,056,414 +215% 09 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 33,787,180 07 Aug 2012 10-Q 10 Aug 2012 2012 Q2
Q1 2012 33,703,370 15 Mar 2012 10-K 23 Mar 2012 2011 FY
Q3 2011 19,527,951 31 Aug 2011 10-Q 02 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.